Dave and Chuck the Freak

Khloé Kardashian attends the CFDA Fashion Awards at Casa Cipriani on November 07, 2022 in New York City.

Khloe Kardashian is once again getting heat for new photos that she posted on Instagram this week from a cover feature for Sorbet Magazine. This time, the Good American founder is clapping back at claims that she uses a controversial diabetes medication to lose weight. When her sister Kim attended last year’s Met Gala 16 pounds lighter, the SKIMS founder sparked accusations of using the drug that resulted in a global shortage. Kim later insisted that she had lost the weight by strict dieting (no carbs and sugar), wearing a sauna suit and running twice a day. “I didn’t starve myself, but I was so strict,” she said on an episode of The Kardashians.

Now, Khloe, 38, is addressing one fan who says her toned, slim body was the result of taking the antidiabetic medication called Semaglutide, known by brand names Ozempic, Wegovy and Rybelsus. The medication is used for the treatment of type 2 diabetes and as an anti-obesity medication for long-term weight management.

RELATED: Fans Mistake Khloe Kardashian For Taylor Swift In New Photos

A follower commented: “The fact that she uses [diabetic] medicine to get this skinny is disturbing.” Khloe then clapped back: “let’s not discredit my years of working out. I get up 5 davs a week at 6am to train. Please stop with your assumptions. I guess new year still means mean people.” Khloe also hit back at fans who claimed that she “changed her face” after she tried out clip-on bangs for the shoot. The reality star shared photos of her with bangs as she credited the hairstyle with changing her face’s shape. She captioned the post: “Fun fact: I wore clip on bangs for this shoot,” she penned. “It was fun to give a different look and not be committed. I am surprised with how much I liked the bangs even though they changed the shape of my face.”